News

Researchers from Vanderbilt University have developed a streamlined diagnostic approach for COVID-19 that renders RNA extraction – a bottleneck in the diagnostic process – unnecessary.

What if we were able to modify the negative effect of a returning memory that makes us afraid? A research group from the University of Bologna succeeded in this and developed a new non-invasive experimental protocol.

The number of adults in the United States who suffer from major depressive episodes at some point in their life is far higher than previously believed, a new study by the Yale School of Public Health finds.

A Swiss-German team has developed a test that determines the amount of SARS-CoV-2 neutralizing antibodies within a short period of time.

We may be able to boost our value of our own bodies by paying more attention to the sensations we feel within, suggests new research.

Trials for specially-trained "COVID dogs" that may be able to detect coronavirus in humans, even before symptoms appear, are now underway.

Positive initial results have been reported for the Phase 2 study of Lyme disease vaccine candidate VLA15.

Researchers have extended the understanding of energy flow in chemical reactions and show that it may produce useful molecular swimmers.

More than 30 million Americans are infected with a brain parasite spread by cats and contaminated meat, but most will never show symptoms. A new discovery explains why, and that finding could have important implications for brain infections, neurodegenerative diseases and autoimmune disorders.

Researchers have mined the U.S. Food and Drug Administration’s Adverse Effect Reporting System (FAERS) database and have discovered that people who received Botox injections reported depression significantly less often than those undergoing alternative treatments for the same condition.